Participation of the serotonin2 receptor in the iminodipropionitrile-induced dyskinetic syndrome
- 1 March 1988
- journal article
- research article
- Published by Elsevier in Experimental Neurology
- Vol. 99 (3) , 589-593
- https://doi.org/10.1016/0014-4886(88)90175-6
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Increased cortical serotonin-2 (5-HT-2) receptors in the iminodipropionitrile (IDPN)-model of persistent dyskinesia in the ratNeuropeptides, 1987
- The dopamine D-2 antagonist, Ro 22-1319, inhibits the persistent behavioral syndrome induced by iminodipropionitrile (IDPN) in miceExperimental Neurology, 1987
- Clonidine and prazosin block the iminodipropionitrile (IDPN)-induced spasmodic dyskinetic syndrome in micePharmacology Biochemistry and Behavior, 1987
- Neurotransmitters and shaking behaviour — more than a ‘gut-bath’ for the brain?Trends in Pharmacological Sciences, 1986
- Decreased striatal opiate δ-receptors in the rat model of persistent dyskinesia induced by iminodipropionitrileNeuroscience Letters, 1986
- Brain Neurotransmitters in Dystonia Musculorum DeformansNew England Journal of Medicine, 1986
- Naltrexone inhibits the persistent spasmodic dyskinesia induced by chronic intraperitoneal administration of iminodipropionitrile (IDPN)Neuropeptides, 1986
- 5-HT-mediated behaviour Animal studiesNeuropharmacology, 1984
- THE EFFECTS OF PUTATIVE 5‐HYDROXYTRYPTAMINE ANTAGONISTS ON THE BEHAVIOUR PRODUCED BY ADMINISTRATION OF TRANYLCYPROMINE AND L‐TRYPTOPHAN OR TRANYLCYPROMINE AND L‐DOPA TO RATSBritish Journal of Pharmacology, 1978
- Factors modifying the head-twitch response to 5-hydroxytryptophanPsychopharmacology, 1973